Abstract

D-Amino acid oxidase can be inactivated by covalent modification of predominantly tyrosine residue(s) at pH 7.4 by a low molar excess of fluorodinitrobenzene, which appears to act as an active site-directed reagent (Nishino, T., Massey, V., and Williams, C. H., Jr. (1980) J. Biol. Chem. 255, 3610-3616). Peptide mapping by high performance liquid chromatography of tryptic digests of protein modified with radiolabeled reagent revealed two major radioactive fractions with substantially different retention times which were not observed in protein modified in the presence of benzoate, a potent competitive inhibitor. Isolation and sequence analysis of the major radiolabeled peptides, as well as other direct chemical analyses, are presented which unambiguously demonstrate that these fractions represent modification of two different regions of the protein. The majority of the radiolabel was found within a 61-amino acid residue peptide containing an O-DNP-tyrosine residue exclusively at position 17. The substantial sequence surrounding this tyrosine residue indicates that it is different from that shown to react with N-chloro-D-leucine (Ronchi, S., Galliano, M., Minchiotti, L., Curti, B., Rudie, N. G., Porter, D. J. T., and Bright, H. J. (1980) J. Biol. Chem. 255, 6044-6046). The second fraction consisted of a 12-residue peptide containing an epsilon-DNP-lysine residue at position 5. Together, these two modified amino acids represented 0.89 mol of DNP incorporated/protein monomer. Both modifications must contribute to inactivation to account for the 90% decrease in enzymatic activity. Evidence is presented which suggests that both groups are within the active center of the enzyme and are modified in a mutually exclusive manner.

Highlights

  • D-Amino acid oxidase can be inactivated by covalent residues per D-amino acid oxidase monomer (1).Inclusion of modification of predominantly tyrosine residue(s) at the competitive inhibitor, benzoate, prevented inactivation pH 7.4 by a low molar excess of fluorodinitrobenzene, and the incorporation of one DNP residue

  • Of protein modified with radiolabeled reagent revealed have shown that a number of nitroaromatic compounds bind two major radioactive fractions with substantially different retentiontimes which were not observed in protein modified in the presence of benzoate, a potent competitive inhibitor

  • The results reported in this communication both support and extend our previous observation that thereagent l-fluoro2,4-dinitrobenzeneserves as an active site-directed inhibitor

Read more

Summary

Supported by Grant GM11106from the National Institutes of

Oro-2,4-dinitrobenzene;TPCK, L-1-tosylamido-2-phenylethylchloromethyl ketone; HPLC, high performance liquid chromatography; The abbreviations used are: DNP, dinitrophenyl; FDNB, l-flu- PTH, phenylthiohydantoin; rt, retention time; im, imidazole. SAitective oOf DxiA-dAcamisdeino l-Fluoro-2,4-dinitrobenzenwe as obtained from Aldrich and used to Amino acid analysis and scintillation counting were performed as dilute [U-I4C]FDNBfrom Amersham to thedesired specific activity. 0-DNP-tyrosine, e-DNP-lysine, a-DNP-methionine, and iodoacetic acid were from Sigma. Im-DNP-Histidine was a gift from Dr Fred. Medical Research Council Laboratory of Molecular Biology, Cambridge, England. L-I-tosylamido-2-phenylethyclhloromethyl ketone (TPCK)-treatedtrypsin was purchased from Worthington, while

RESULTS
Methods
40 His that this peak represents the first 26 residues from the NH2
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call